We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ATAI market cap is 249.19M. The company's latest EPS is USD -0.2397 and P/E is -6.42.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 87k | 18k | 205k | 273k | 40k |
| Operating Income | -57.36M | -77.66M | -23.88M | -25.73M | -22.61M |
| Net Income | 44.25M | -18.29M | -26.71M | -57.31M | -26.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 20.38M | 233k | 314k |
| Operating Income | -17.23M | -104.58M | -135.63M | -141.83M | -125.41M |
| Net Income | -14.14M | -169.84M | -167.81M | -152.39M | -40.22M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 308.22M | 293.48M | 269.12M | 215.78M | 197.52M |
| Total Liabilities | 39.71M | 49.16M | 45.86M | 47.25M | 51.2M |
| Total Equity | 268.51M | 244.32M | 223.26M | 168.53M | 146.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.12M | 111.55M | 414.17M | 305.44M | 293.48M |
| Total Liabilities | 2.48M | 16.18M | 28.21M | 39.68M | 49.16M |
| Total Equity | 59.64M | 95.37M | 385.96M | 265.77M | 244.32M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -62.16M | -84.12M | N/A | -38.8M | -58.14M |
| Investing | -52.47M | -53.3M | N/A | 27.77M | 52.61M |
| Financing | 106k | -8.36M | N/A | 326k | 5.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.85M | -20.77M | -63.25M | -104.47M | -84.12M |
| Investing | -9.03M | -28.27M | -81.28M | -86.85M | -53.3M |
| Financing | 40.39M | 113.05M | 409.86M | 20.79M | -8.36M |
| Market Cap | 249.19M |
| Price to Earnings Ratio | -6.42 |
| Price to Sales Ratio | 810.53 |
| Price to Cash Ratio | 5.74 |
| Price to Book Ratio | 1.06 |
| Dividend Yield | - |
| Shares Outstanding | 167.8M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 1.85M |
| 52 Week Change | -13.66% |
| 52 Week High | 2.85 |
| 52 Week Low | 1.03 |
| Spread (Intraday) | 0.01 (0.67%) |
| Company Name | ATAI Life Sciences NV |
| Address |
wallstrabe 16 berlin 10179 |
| Website | https://www.atai.life |
| Industry | intermediate care facilities (8052) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
